Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Subtle Medical Appoints Ohad Arazi As Chief Executive Officer

PRIVATEJun 02, 2026•15 days ago

Position

Chief Science Officer

Company

Subtle Medical

Enhao Gong
Menlo Park

Description

Subtle Medical has announced the appointment of Ohad Arazi as Chief Executive Officer as part of their next phase of growth. The company has also secured $33 million in growth capital to accelerate product development and expand commercial adoption globally.

Company Information

Company

Subtle Medical

Location

Menlo Park, California, United States

About

Subtle Medical, Inc. is a healthcare technology company with deep learning solutions that improve workflow efficiency and patient experience. The company has the first AI software solutions FDA-cleared for medical imaging enhancement, SubtlePET™ and SubtleMR™. It was named CB Insights Top AI 100 and Digital Health 150 company in 2020 and is an Nvidia Inception Award Winner.  Current clinical partners include UCSF, Hoag Hospital, Mt. Sinai, Sickkids, Radnet, DASA, Tiantan Hospital, and Middlesex Hospital, among others. Subtle is currently in collaboration with top-tier medical device vendors, including Siemens Healthineers, GE Healthcare, Philips (China) and several pharmaceutical partners. Subtle was founded in 2017.  Seed investors include Bessemer Venture Partners, Zhenfund (Momentor Ventures), Data Collective, Breyer Capital, and Baidu Ventures, among others. For more information, please visit subtlemedical.com or email [email protected].

Predictive Intelligence
Strategic

ML-powered predictions for Subtle Medical's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.